Factors associated with positive Mantoux results in NHS healthcare workers

Edet, A; Turner, Sasha

doi:10.1093/occmed/kqy051

Cited by 2 publications

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Providing a definitive diagnostic test such as the IGRA testing to HCW with positive TST could enhance treatment uptake. Some HCWs felt that TST was not diagnostic and there is a possibility of false positive results due to multiple factors such as the misconception of history of BCG vaccination and working in an environment with continuous exposure to active TB [ 35 ]. In TST-positive patients, studies had supported the use of IGRA to reduce false positive results of TST and improve clinical management of LTBI [ 36 , 37 ].…”

Section: Discussionmentioning

confidence: 99%

Facilitators and barriers to latent tuberculosis infection treatment among primary healthcare workers in Malaysia: a qualitative study

H.,

Manoharan,

Koh

et al. 2023

BMC Health Serv Res

View full text Add to dashboard Cite

Background Healthcare workers (HCWs) have an increased risk of active and latent tuberculosis infection (LTBI) compared to the general population. Despite existing guidelines on the prevention and management of LTBI, little is known about why HCWs who tested positive for LTBI refuse treatment. This qualitative study sought to explore the facilitators and barriers to LBTI treatment uptake among primary HCWs in Malaysia. Methods This qualitative study used a phenomenological research design and was conducted from July 2019 to January 2021. A semi-structured topic guide was developed based on literature and the Common-Sense Model of Self-Regulation. We conducted one focus group discussion and 15 in-depth interviews with primary care HCWs. Interviewees were 7 physicians and 11 allied HCWs who tested positive for LTBI by Tuberculin Skin Test or Interferon Gamma Release Assay. Audio recordings were transcribed verbatim and thematic analysis was used to analyse the data. Results We found four factors that serve as barriers to HCWs’ LTBI treatment uptake. Uncertainties about the need for LTBI treatment, alongside several other factors including the attitude of the treating physician towards treatment, time constraints during clinical consultations, and concerns about the treatment itself. On the other hand, facilitators for LTBI treatment uptake can be grouped into two themes: diagnostic modalities and improving knowledge of LTBI treatment. Conclusions Improving HCWs’ knowledge and informative clinical consultation on LTBI and its treatment benefit, aided with a definitive diagnostic test can facilitate treatment uptake. Additionally, there is a need to improve infection control measures at the workplace to protect HCWs. Utilizing behavioural insights can help modify risk perception among HCWs and promote treatment uptake.

show abstract

Section: Discussionmentioning

confidence: 99%